Altered glycosylation of the dopamine transporter (DAT), a protein crucial for the reuptake of dopamine from the synaptic cleft, can disrupt dopamine homeostasis, leading to synaptic dysfunction in the dopaminergic pathways that are severely affected in PD [229]. Here, SLC6A3 is linked to Parkinson disease.